Welcome!

News Feed Item

Eisai Launches New Comprehensive Information Website about Neglected Tropical Diseases and Elimination Initiatives

Tokyo, Apr 24, 2014 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai") announced today that it has launched a new comprehensive information website called the "Eisai Access to Medicines (ATM) Navigator" (http://atm.eisai.co.jp/english/) which provides information on Neglected Tropical Diseases (NTDs) and the various initiatives to eliminate these diseases in an easy to understand way.

Many developing countries throughout the world are faced with problems of Access to Medicines (ATM), which occurs when issues such as poverty and underdeveloped medical systems result in essential medicines being unable to reach the people who need them. This is especially the case with NTDs, which are a group of tropical infections that are endemic to 149 countries worldwide, primarily affecting poor people in developing and emerging countries with over 1 billion people infected. Despite most of these diseases having been treated and eliminated already in developed countries, in countries which are endemic to NTDs, patients are unable to get access to medical treatment, which is a global access to medicines issue. This is caused by a number of complex factors in endemic countries such as inadequate medical supply systems, a lack of information about diseases, and the limited adoption of disease diagnosis, prevention and treatment methods. In order to solve these issues, co-operation between governments, non-government organizations (NGOs) and pharmaceutical companies is required.

The "Eisai ATM Navigator" provides content that explains the causes, symptoms, infected regions, treatments and prevention methods for the 17 NTDs prioritized by the World Health Organization (WHO) as well as the three infectious diseases of HIV/AIDS, malaria and tuberculosis, in an easy to understand way. The website is for patients, the general public, healthcare professionals and volunteers in both developed and endemic countries. The website also introduces elimination initiatives implemented by pharmaceutical companies and other organizations.
Providing this kind of information through the website, Eisai aims to promote awareness regarding issues of Access to Medicines and NTDs among people around the world, as well as increase understanding of these diseases among people such as patients who suffer from NTDs, those at risk of infection, local healthcare professionals and volunteers, in order to help contribute toward the future elimination of NTDs.

Notes:

1. About the "Eisai Access to Medicines (ATM) Navigator" Website
This is the first Japanese and English bilingual website that comprehensively provides information on topics such as NTDs, HIV/AIDS, malaria and tuberculosis, initiatives to eliminate these diseases and improve Access to Medicines for patients, the general public, healthcare professionals and volunteers in both developed and disease endemic countries. Giving consideration to the increasing usage of smartphones around the world, the website is also designed so that people in affected regions can easily view the site on smartphones as well.

The content on this website is supervised by tropical medicine researchers Dr. Tsutomu Takeuchi, Professor Emeritus and Visiting Senior Research Fellow at the Keio University Global Security Research Institute, and Dr. Hiroyoshi Endo, Professor at the Department of International Affairs and Tropical Medicine, School of Medicine, Tokyo Women's Medical University.

The main contents provided on the site are as follows:

- What is ATM: Outlines the definition of the "Access to Medicines Issue" and approaches toward improving Access to Medicines. The issue of access to medicines is that proper medicines and medical treatments are unavailable to patients in need for reasons of poverty, underdeveloped healthcare systems or other factors, particularly in the context of high-growth emerging countries and the developing world.

- About NTDs: Explains the causes, symptoms, infected regions, treatment and prevention methods of the 17 NTDs prioritized by WHO in an easy to understand way.

- Eliminating Lymphatic Filariasis: Introduces Eisai's initiatives to eliminate lymphatic filariasis. DEC (diethylcarbamazine) is one of the three drugs used to treat lymphatic filariasis and is in short supply around the world. Eisai is producing high quality DEC tablets and providing them for free to endemic countries through WHO's mass drug administration programs in order to achieve the goal of eliminating lymphatic filariasis by 2020.

- New Drug Development: Advanced countries have not been enthusiastic in developing new drugs or vaccines for the NTDs affecting developing and emerging countries because demand is low in their own countries. As a result, there are very few effective new drugs for many of these diseases even today. This section introduces examples of international collaboration in research and development which aim to create new drugs to address these needs.

- Medical Information: Provides a package insert (drug information) for healthcare professionals regarding Eisai's DEC tablets for the treatment of lymphatic filariasis which is being supplied for free through WHO, as well as a leaflet that explains the purpose of taking medicine in an easy to understand way for volunteers, patients and the general public.

- Field Reports: Presents reports by Eisai and its supporters on Access to Medicines initiatives being implemented around the world.

2. About Neglected Tropical Diseases (NTDs)

Neglected tropical diseases (NTDs) include 17 tropical diseases that the WHO (World Health Organization) identifies as diseases that the world must overcome. Prominent among them are lymphatic filariasis, Chagas' disease, and dengue fever.
NTDs are endemic in 149 countries, infecting some 1 billion people and creating serious social difficulties. Among these countries, two NTDs are endemic in 100 countries and territories, while more than six NTDs are endemic in 30 countries and territories.

Although the spread of NTDs is mainly caused by poor hygienic conditions associated with poverty, infections from these diseases may result in serious physical impairment which in turn leads to declines in the work force and productivity, thereby hampering efforts to escape from impoverished conditions. As such, the prevalence of NTDs is a stumbling block to economic growth for developing and emerging countries and represents a serious issue for these regions.

*The 17 NTDs are: Lymphatic filariasis, Chagas' disease, the leishmaniases, dracunculiasis, human African trypanosomiasis, blinding trachoma, leprosy, schistosomiasis, onchocerciasis, soil-transmitted helminthiasis, Buruli ulcer, dengue fever, cysticercosis, rabies, echinococcosis, foodborne trematodiases and endemic treponematoses

About Eisai

Eisai Co., Ltd. (TSE: 4523; ADR: ESALY) is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: integrative neuroscience, including neurology and psychiatric medicines; integrative oncology, which encompasses oncotherapy and supportive-care treatments; and vascular/immunological reaction. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system. For more information about Eisai Co., Ltd., please visit www.eisai.com.



Source: Eisai

Contact:
Public Relations Department,
Eisai Co., Ltd.
+81-3-3817-5120


Copyright 2014 JCN Newswire. All rights reserved. www.japancorp.net

More Stories By JCN Newswire

Copyright 2008 JCN Newswire. All rights reserved. Republication or redistribution of JCN Newswire content is expressly prohibited without the prior written consent of JCN Newswire. JCN Newswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Hitrons Solutions will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Hitrons Solutions Inc. is distributor in the North American market for unique products and services of small and medium-size businesses, including cloud services and solutions, SEO marketing platforms, and mobile applications.
With the introduction of IoT and Smart Living in every aspect of our lives, one question has become relevant: What are the security implications? To answer this, first we have to look and explore the security models of the technologies that IoT is founded upon. In his session at @ThingsExpo, Nevi Kaja, a Research Engineer at Ford Motor Company, will discuss some of the security challenges of the IoT infrastructure and relate how these aspects impact Smart Living. The material will be delivered i...
For organizations that have amassed large sums of software complexity, taking a microservices approach is the first step toward DevOps and continuous improvement / development. Integrating system-level analysis with microservices makes it easier to change and add functionality to applications at any time without the increase of risk. Before you start big transformation projects or a cloud migration, make sure these changes won’t take down your entire organization.
Historically, some banking activities such as trading have been relying heavily on analytics and cutting edge algorithmic tools. The coming of age of powerful data analytics solutions combined with the development of intelligent algorithms have created new opportunities for financial institutions. In his session at 20th Cloud Expo, Sebastien Meunier, Head of Digital for North America at Chappuis Halder & Co., will discuss how these tools can be leveraged to develop a lasting competitive advanta...
What if you could build a web application that could support true web-scale traffic without having to ever provision or manage a single server? Sounds magical, and it is! In his session at 20th Cloud Expo, Chris Munns, Senior Developer Advocate for Serverless Applications at Amazon Web Services, will show how to build a serverless website that scales automatically using services like AWS Lambda, Amazon API Gateway, and Amazon S3. We will review several frameworks that can help you build serverle...
Your homes and cars can be automated and self-serviced. Why can't your storage? From simply asking questions to analyze and troubleshoot your infrastructure, to provisioning storage with snapshots, recovery and replication, your wildest sci-fi dream has come true. In his session at @DevOpsSummit at 20th Cloud Expo, Dan Florea, Director of Product Management at Tintri, will provide a ChatOps demo where you can talk to your storage and manage it from anywhere, through Slack and similar services ...
VeriStor Systems has announced that CRN has named VeriStor to its 2017 Managed Service Provider (MSP) 500 list in the Elite 150 category. This annual list recognizes North American solution providers with cutting-edge approaches to delivering managed services. Their offerings help companies navigate the complex and ever-changing landscape of IT, improve operational efficiencies, and maximize their return on IT investments. In today’s fast-paced business environments, MSPs play an important role...
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
SYS-CON Events announced today that Cloudistics, an on-premises cloud computing company, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Cloudistics delivers a complete public cloud experience with composable on-premises infrastructures to medium and large enterprises. Its software-defined technology natively converges network, storage, compute, virtualization, and management into a ...
Keeping pace with advancements in software delivery processes and tooling is taxing even for the most proficient organizations. Point tools, platforms, open source and the increasing adoption of private and public cloud services requires strong engineering rigor - all in the face of developer demands to use the tools of choice. As Agile has settled in as a mainstream practice, now DevOps has emerged as the next wave to improve software delivery speed and output. To make DevOps work, organization...
SYS-CON Events announced today that Juniper Networks (NYSE: JNPR), an industry leader in automated, scalable and secure networks, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Juniper Networks challenges the status quo with products, solutions and services that transform the economics of networking. The company co-innovates with customers and partners to deliver automated, scalable and secure network...
My team embarked on building a data lake for our sales and marketing data to better understand customer journeys. This required building a hybrid data pipeline to connect our cloud CRM with the new Hadoop Data Lake. One challenge is that IT was not in a position to provide support until we proved value and marketing did not have the experience, so we embarked on the journey ourselves within the product marketing team for our line of business within Progress. In his session at @BigDataExpo, Sum...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In his Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will explore t...
SYS-CON Events announced today that Ocean9will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Ocean9 provides cloud services for Backup, Disaster Recovery (DRaaS) and instant Innovation, and redefines enterprise infrastructure with its cloud native subscription offerings for mission critical SAP workloads.
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.